Recently, inversion tables have been gaining a lot of attention as more people search for solutions to alleviate back pain and enhance their overall wellbeing. These tables let individuals suspend ...

The FDA has rejected a rare blood disease candidate from Disc Medicine, a compound that had been granted expedited review through a newly launched priority voucher program. While the agency agreed ...

US Senator Chuck Schumer is determined to close the loophole that is allowing corporations to keep assets out of reach of the US taxman, and aims to claw back money from deals stretching back two ...

Feb 13 (Reuters) - Disc Medicine (IRON.O), opens new tab said on Friday the U.S. Food and Drug Administration declined to approve its drug to treat a rare genetic disorder. The drug, bitopertin, was ...

A substantial insider sell was reported on February 11, by John H Batten, President and CEO at Twin Disc (NASDAQ:TWIN), based on the recent SEC filing. What Happened: According to a Form 4 filing with ...

Spring training opens across baseball this week as pitchers and catchers begin reporting to camp. For the Colorado Rockies, they're due on Thursday. Still, there was a transaction on Tuesday that ...

Feb 13 (Reuters) - Disc Medicine said on Friday the U.S. Food and Drug Administration has declined to approve its drug to treat a rare genetic disorder, sending its shares down 31.6% to $48.90. The ...

Objectives Acute anterior ischaemic optic neuropathy (AION) is a feared ischaemic complication of giant cell arteritis (GCA).

Sarah Jividen, RN, BSN, is a trained neuro/trauma, and emergency room nurse turned healthcare writer. As a journalism major, she combined her love for writing with her passion for high-level patient ...

From advances in artificial intelligence and blockchain to precision agriculture, statistical innovation drives progress. A new National Academies report examines key developments in statistics, ...